Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model ; volume:7 ; number:1 ; day:27 ; month:10 ; year:2017 ; pages:1-11 ; date:12.2017
Scientific reports ; 7, Heft 1 (27.10.2017), 1-11, 12.2017
- Urheber
-
Bargsted, Leslie
Medinas, Danilo B.
Martínez Traub, Francisca
Rozas, Pablo
Muñoz, Natalia
Nassif, Melissa
Jerez, Carolina
Catenaccio, Alejandra
Court, Felipe A.
Hetz, Claudio
Matus, Soledad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-14399-5
- URN
-
urn:nbn:de:101:1-2019102021060601763597
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.03.1971, 00:00 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bargsted, Leslie
- Medinas, Danilo B.
- Martínez Traub, Francisca
- Rozas, Pablo
- Muñoz, Natalia
- Nassif, Melissa
- Jerez, Carolina
- Catenaccio, Alejandra
- Court, Felipe A.
- Hetz, Claudio
- Matus, Soledad
- SpringerLink (Online service)
Ähnliche Objekte (12)
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
Exploring cellular toxicity mechanisms and immunotherapeutic potential of TDP-43 in ALS/FTD
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity
Linking neurodegeneration to vascular dysfunction - Loss of ALS/FTD-associated TDP-43 causes angiogenic defects
Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C
Author Correction: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
Exploring cellular toxicity mechanisms and immunotherapeutic potential of TDP-43 in ALS/FTD
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity
Linking neurodegeneration to vascular dysfunction - Loss of ALS/FTD-associated TDP-43 causes angiogenic defects
Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C
Author Correction: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
Exploring cellular toxicity mechanisms and immunotherapeutic potential of TDP-43 in ALS/FTD
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity
Linking neurodegeneration to vascular dysfunction - Loss of ALS/FTD-associated TDP-43 causes angiogenic defects
Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C